Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence Caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial

NCT05703178 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT05703178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05703178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence Caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial
Lead sponsor
Northwestern University
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 19, 2023
Completion date
May 1, 2027
Enrollment
452 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arthralgia, breast cancer, pain, chronic